CareDx, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
CDNA Nasdaq 3840 caredx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for CareDx, Inc.

CareDx (CDNA) Is Up 39.4% After Medicare Clarifies Transplant Test Coverage Limits - What's Changed - Jul 18th, 2026 3:08 pm
CareDx (CDNA) Secures Medicare Reimbursement Clarity, Is The Upside Already Priced In? - Jul 18th, 2026 10:08 am
CareDx (CDNA) Stock May Be Fully Valued Despite Medicare Coverage News - Jul 18th, 2026 6:11 am
CareDx (CDNA) Moves 35.6% Higher: Will This Strength Last? - Jul 17th, 2026 3:16 am
CareDx shares jump as Medicare finalizes transplant testing coverage policy (CDNA) - Jul 16th, 2026 7:43 am
CareDx to Report Second Quarter 2026 Financial Results on July 30, 2026 - Jul 16th, 2026 6:35 am
CareDx Announces Finalization of Solid Organ Transplant Molecular Testing Local Coverage Determination - Jul 16th, 2026 6:30 am
CareDx Acquires Naveris, Extends Leadership into High-Growth Specialty Oncology - Jul 2nd, 2026 4:41 pm
CareDx Completes Acquisition of Naveris, Extending Leadership into High-Growth Specialty Oncology - Jul 1st, 2026 2:05 pm
Eurobio Scientific finalizes the acquisition of CareDX’s transplant Lab Product division - Jul 1st, 2026 12:00 am
CareDx Announces Completion of Sale of Lab Products Business to Eurobio Scientific - Jun 30th, 2026 2:05 pm
CareDx's CEO Sells 17K Shares - Jun 21st, 2026 7:58 pm
CareDx (CDNA) Moves 11.5% Higher: Will This Strength Last? - Jun 19th, 2026 5:39 am
CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress - Jun 18th, 2026 5:05 am
CareDx Announces Second KOAR Analysis Published in the Journal of the American Society of Nephrology - Jun 16th, 2026 2:05 pm
CareDx (CDNA) Valuation Check After Choppy Trading And Growing AI Diagnostics Story - Jun 9th, 2026 8:11 am
CareDx Sharpens Precision Diagnostics Push With Naveris Deal, AlloHeme Plans - Jun 8th, 2026 6:03 pm
CareDx Highlights 39% Q1 Growth, Naveris Oncology Push at Jefferies - Jun 7th, 2026 4:03 am
A Look At CareDx (CDNA) Valuation After Recent Share Price Momentum Cools - May 4th, 2026 5:15 pm
CareDx, Inc Q1 2026 Earnings Call Summary - Apr 29th, 2026 6:30 am